|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||327.24 - 334.80|
|52 Week Range||231.90 - 341.30|
|Beta (3Y Monthly)||0.76|
|PE Ratio (TTM)||33.94|
|Forward Dividend & Yield||2.00 (0.61%)|
|1y Target Est||N/A|
Wall Street analysts expect Thermo Fisher Scientific’s (TMO) third-quarter revenues to increase ~11.5% to $5.7 billion—compared to its revenues of $5.1 million during the third quarter of 2017. The adjusted EPS is estimated to be $2.55 for the third quarter—compared to the adjusted EPS of $2.31 in the third quarter of 2017.
Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Many of us are unhappy with our health insurers. Premiums are high. Hospital bills can be large and deductibles for many policyholders are larger than ever. But the world looks good if you own health insurance stocks. There are profits to be made managing government health care programs -- Medicaid, public exchanges, the Children's Health Insurance Program and Medicare. Because despite the confusion over health insurance, government health care expenditures continue to rise. To wit, Medicare spending is projected grow 7.9% annually to 2023 with total expenditures of approximately $1.1 trillion. Meanwhile, Medicaid spending is estimated to grow 5.9% annually to 2023, when it will top $828 billion. Here are five health insurance stocks to buy - all of which have advanced by double digits already in 2018. But don't worry about being late to the party. There's reason to expect more upside in these stocks because they need only to maintain a strategy at which they have proven adept: increase enrollments and contain medical costs. SEE ALSO: 25 Stocks Every Retiree Should Own
UnitedHealth Group is a leading managed healthcare firm in the United States. It offers healthcare products and insurance services through its two divisions: UnitedHealthcare and Optum. The company recently acquired Genoa Healthcare to expand its OptumRx business.
An increasing number of memberships, with unemployment rate hitting a record low, have been one of the prime factors behind the top-line growth of the health insurance sector.
The pushback against Gov. Rick Scott’s effort to create a health-care transparency website appears to be more widespread than state officials previously acknowledged. Members of a statewide advisory panel were told this week that the Agency for Health Care Administration is “in the process of working with” insurance giant Florida Blue on getting claims data to use for the long-promised website that is supposed to help consumers compare health-care prices. AvMed, a Florida-based health maintenance organization, also is not submitting the information to the state, AHCA spokesperson Mallory McManus said.
Higher enrollment, premium increase, cost management and share buyback should aid health insurers' earnings in the third quarter, partly offset by higher operating costs.
Fitbit (FIT) unveils a new enterprise health care platform and also expands its partnership with Humana in a bid to expand its share in the healthcare market.
DaVita (DVA) reported revenues of ~$2.9 billion in the second quarter of 2018, which is a 6.9% YoY (year-over-year) growth compared to $2.7 billion in the second quarter of 2017. DaVita reported 6.9% growth in its top line to $2.89 billion, including an 11.1% growth in revenues from US dialysis and related lab services to $2.57 billion, offset by a 17.7% decrease in revenues for other ancillary services and strategic initiatives in the second quarter of 2018. Medicare and Medicare Advantage revenues were $1.5 billion in the second quarter of 2018, a 16.2% growth compared to $1.3 billion in the second quarter of 2017.
President & CEO of Humana Inc (NYSE:HUM) Bruce D Broussard sold 18,000 shares of HUM on 09/10/2018 at an average price of $328.66 a share.
I am writing today to help inform people who are new to the stock market and want to begin learning about how to value company based on its current earningsRead More...
In this article I am going to calculate the intrinsic value of Humana Inc (NYSE:HUM) by taking the foreast future cash flows of the company and discounting them back toRead More...